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Abstract
Background: Tobacco smoking is a serious risk to health: several therapies are available to assist
those who wish to stop. Smokers who approach publicly funded stop-smoking clinics in the UK are
currently offered nicotine replacement therapy (NRT) or bupropion, and group behaviour therapy,
for which there is evidence of effectiveness. Acupuncture and acupressure are also used to help
smokers, though a systematic review of the evidence of their effectiveness was inconclusive. The
aim of this pilot project was to determine the feasibility of a study to test acupressure as an adjunct
to one anti-smoking treatment currently offered, and to inform the design of the study.
Methods: An open randomised controlled pilot study was conducted within the six week group
programme offered by the Smoking Advice Service in Plymouth, UK. All participants received the
usual treatment with NRT and group behavioural therapy, and were randomised into three groups:
group A with two auricular acupressure beads, group B with one bead, and group C with no
additional therapy. Participants were taught to press the beads when they experienced cravings.
Beads were worn in one ear for four weeks, being replaced as necessary. The main outcome
measures assessed in the pilot were success at quitting (expired CO ≤ 9 ppm), the dose of NRT
used, and the rating of withdrawal symptoms using the Mood and Symptoms Scale.
Results: From 49 smokers attending four clinics, 24 volunteered to participate, 19 attended at
least once after quitting, and seven remained to the final week. Participants who dropped out
reported significantly fewer previous quit attempts, but no other significant differences. Participants
reported stimulating the beads as expected during the initial days after quitting, but most soon
reduced the frequency of stimulation. The discomfort caused by the beads was minor, and there
were no significant side effects. There were technical problems with adhesiveness of the dressing.
Reporting of NRT consumption was poor, with much missing data, but reporting of ratings of
withdrawal symptom scores was nearly complete. However, these showed no significant changes
or differences between groups for any week.
Conclusion: Any effects of acupressure on smoking withdrawal, as an adjunct to the use of NRT
and behavioural intervention, are unlikely to be detectable by the methods used here and further
preliminary studies are required before the hypothesis can be tested.
Published: 14 March 2007
BMC Complementary and Alternative Medicine 2007, 7:8 doi:10.1186/1472-6882-7-8
Received: 8 August 2006
Accepted: 14 March 2007
This article is available from: http://www.biomedcentral.com/1472-6882/7/8
© 2007 White et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9
(page number not for citation purposes)
BMC Complementary and Alternative Medicine 2007, 7:8 http://www.biomedcentral.com/1472-6882/7/8Background
Smoking is recognised as a major cause of ill health, and
in developed countries cigarettes are the single biggest
avoidable cause of death and disability [1], so that quit-
ting smoking is generally the single most important action
that any individual can take to improve health [2]. But
stopping smoking is known to be difficult, mainly
because of nicotine withdrawal symptoms. Most smokers
wish they were non-smokers, but their attempts to stop
frequently fail [3]. The unassisted quit rate at one year is
about 3% [4], and a wide range of interventions have been
proposed to help those who want to quit.
One such intervention is acupuncture, which has been
used for centuries in China for treating opium withdrawal
symptoms [5]. Acupuncture using only points in the ear
(auricular acupuncture) was found by chance to help
withdrawal in opium smokers in Hong Kong in the 1970s
[6]. One common technique of auricular acupuncture
involves inserting an small indwelling needle in the ear,
which is pressed by the wearer whenever cravings occur.
The needle should be removed and replaced frequently to
avoid infection.
There is some evidence that acupuncture may act on the
nucleus accumbens to inhibit the rise in dopamine which
seems to be the common pathway for withdrawal symp-
toms [7,8]. However, a systematic review of the acupunc-
ture literature found that, overall, the evidence was
inconclusive on whether acupuncture is clinically effective
for nicotine withdrawal [9]. A subsequent review which
explored the data for auricular acupuncture only sug-
gested that this result might be a false negative [10]. Most
controlled trials had compared the 'correct' sites with
'incorrect' sites on the ear, but there is some doubt
whether any sites in the ear can be regarded as 'incorrect'.
Auricular acupuncture was more effective than other inter-
ventions it was compared with, but not more effective
than treatment at 'incorrect' sites.
Other interventions for smoking cessation have devel-
oped an evidence base, and there is now clear evidence to
support pharmacological therapy with nicotine replace-
ment therapy (NRT) or bupropion, to reduce withdrawal
symptoms [4]; and psychological therapies including edu-
cation, support, and behavioural therapy on either a
group [11] or individual basis [12] to deal with the behav-
ioural aspects of quitting. Some of these therapies may
double the abstinence rate at one year [13]. They are now
widely available in England as part of the NHS Stop
Smoking Service set up in response to the Government's
White Paper Smoking Kills [14]. Data available for the
clinic in Plymouth show that over 300 patients attended
courses of these interventions in 2003 (Smoking Advice
Service report April 2004).
In the context of the success of NRT and counselling, it is
reasonable to ask whether acupuncture has a role as a pos-
sible adjunct. There is some evidence that combining dif-
ferent methods for quitting increases success rates more
than by simple addition [15]. It would be of interest if
acupuncture could either further reduce the withdrawal
symptoms and increase the success rate, or reduce the use
of NRT and possibly minimise total costs of the interven-
tion.
However, auricular acupuncture with indwelling needles
is not without problems, particularly the risk of lost nee-
dles causing spread of blood borne infection. The major
professional body of medical acupuncturists in the UK no
longer recommends the use of indwelling needles [16].
Therefore small beads (acupressure) are commonly used
as a substitute and one study found them superior to
advice alone in smoking cessation [17]. We decided to
conduct a pilot study of acupressure within the setting of
the Stop Smoking Service, to explore the feasibility of con-
ducting a full scale randomised controlled trial. We
wished to address the questions of a) the accrual and
dropout rates, b) compliance with stimulation of beads,
c) adverse events. We also wished to explore the feasibility
of the planned outcome measures, involving d) compli-
ance with completing symptom diaries and e) methods to
monitor the use of NRT. In addition, we sought f) infor-
mation on outcome data variance and possible effect size,
for sample size calculation.
Methods
An open pilot RCT was conducted with three arms: two
treatment groups with one or two acupressure beads, and
a control group who received no acupressure. All partici-
pants received usual therapy. Approval was given by the
South West Devon Research Ethics Committee (04/
Q2103/154).
The study was run within the group therapy service of the
community based, NHS-funded Smoking Advice Service
in Plymouth. Smokers join a Quit Smoking Group which
meets for six consecutive weeks (Table 1). At the initial
meeting, smokers are offered general information and
motivational and behavioural counselling, and given a
letter to the GP recommending the dose of NRT or, more
rarely, bupropion tailored to the individual according to
their smoking history. The quit date is set for the second
session one week later, when members of the group
smoke their last cigarette and take their medication for the
first time. Four subsequent weekly meetings offer moni-
toring, advice and group support.
Smokers were invited to join the study by letter which
included the study information sheet and questionnaire,
sent before their first meeting. At the first group session,Page 2 of 9
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sion if they smoked ≥ 10 cigarettes/day, were aged 18
years or over, intended to stop smoking on the quit date,
chose NRT rather than bupropion, and gave informed
consent. Exclusion criteria were: history of current otitis
externa or other pathological condition of the ear, history
of a poorly controlled relevant medical condition, cur-
rently taking anti-depressant or anti-psychotic medica-
tion, history of allergy to adhesive dressing, belief of
pregnancy, or already participating in a research project.
All smokers wishing to join the study were interviewed on
first attendance by AW or RM; they then gave consent and
provided socio-demographic information and smoking
history including the Fagerstrom severity questionnaire.
All participants in the study received the usual NRT and
group counselling and support; on the quit date, partici-
pants opened an opaque, numbered envelope containing
a code generated by computerised blocked randomisation
(blocks of four) prepared by a researcher unconnected
with the study. The three codes indicated A) two acupres-
sure beads B) one bead, both in addition to the usual
interventions, and C) usual interventions only.
Acupressure interventions
In the intervention groups, beads were applied on the sec-
ond attendance (quit day) by AW or RM. Beads were of
Pyonex® type, manufactured without a needle for this
study (Seirin, Japan).
In group A, two beads were placed, using the so-called
'Lung' and 'Shenmen' points of the ear; in group B, one
bead was placed at Lung point. These points are the two
most commonly used in the literature [18] and included
in a manual [19]. They were identified by inspection of
surface anatomy, looking for the most prominent depres-
sion in the centre of the concha (Lung point), and the
anterior angle of the triangular fossa (Shenmen). The
dominant side of the body was used in the first instance.
Participants were given oral and written instructions on
how to tap, press or squeeze the beads repeatedly for up
to a minute each time a craving occurs. They were also
advised on maintaining local hygiene, and on possible
adverse events and how to deal with them including how
to remove the bead if it became painful. They were also
asked to bring their empty packets of NRT to subsequent
clinics, to allow direct assessment of NRT consumption.
All participants' GPs were informed by letter of their par-
ticipation in the trial.
At each subsequent weekly visit, the ear was inspected.
Each bead was removed after 14 days, or earlier if inflam-
mation was present, and fresh bead(s) placed in the oppo-
site ear, using the same location(s). Beads were worn
throughout the period of attendance of groups (i.e. the
first 4 weeks of withdrawal) and removed at the last
attendance.
Outcomes
The proposed outcomes to measure the intended effect of
acupressure were NRT consumption and nicotine with-
drawal symptoms.
We aimed to measure consumption of NRT (patch, gum,
microtablets, lozenges or inhalator) in two ways: both
from counting used packs at each attendance,[20] and
from reports in daily diaries. We assessed withdrawal
symptoms using the seven-item Mood and Physical
Symptoms Scale (MPSS) [21,22]. The MPSS is sensitive to
changes resulting from abstinence [23]: smokers rate the
severity of depression, irritability, restlessness, hunger,
poor concentration, anxiety and insomnia. We also asked
them to rate cravings with the questions 'time spent in
urge to smoke' and 'strength of urge to smoke'. We asked
one additional question to rate severity of constipation, as
discussed by one author [23]. All these measures used
five-point scales. Since withdrawal symptoms were an
important focus of the study, we asked participants to
score the diary daily. Initially, we asked participants to
complete the MPSS for just three days in the week before
quit date, as recommended. However, when one partici-
pant continued to do this for the following week, we
altered our procedures to ask participants to complete the
diary for seven days for all five weeks of the trial period.
The planned secondary outcomes were: quit rate at four
weeks defined as self-reported cessation, validated by car-
bon monoxide concentration in expired air of ≤ 9 ppm,
Table 1: Study flow chart indicating the acupressure study running alongside the usual smoking clinics
clinic attendance 1 2 3 4 5 6
Smoking Advice 
Service activity
advice; 
prescription for 
nicotine 
replacement
QUIT DATE 1st 
nicotine 
replacement
behavioural 
support & 
compliance
behavioural 
support & 
compliance
behavioural 
support & 
compliance
behavioural 
support & 
compliance
acupressure study 
activity
information, 
consent
groups A & B: 
bead(s) placed
replaced if 
necessary
replaced if 
necessary
replaced if 
necessary
removed
study diary issued run-in quit 1 quit 2 quit 3 quit 4Page 3 of 9
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(Bedfont Scientific Ltd, Bedfont House, Holywell Lane,
Upchurch, Kent UK) calibrated at the start of trial; and
how much discomfort the beads caused (five point scale
from none to extreme) recorded in the daily diary. We also
asked participants to record how many times they stimu-
lated the beads over 24 hours (in five categories: none, <
5, 5–9, 10–20 and over 20 times), on the premise that a
minimum of 5 times would be necessary in the first two
weeks unless the bead was already causing discomfort.
At each clinic attendance, participants were interviewed
by either AW or RM. They were asked whether they had
experienced any adverse events during the previous week
that might have been due to NRT or acupressure. This
information and CO reading were recorded in a clinic
data sheet.
Analysis
Data were entered into Excel spreadsheets by clinic staff
with reference to the usual clinic records where necessary
e.g. for missing CO readings.
For the analysis of outcomes, missing data were handled
as follows: for NRT use, blank cells indicating possible
missing data were completed or not according to the con-
text, which was usually daily application of a nicotine
patch. For MPSS, we could not find published guidelines,
and none were available from the author (Robert West,
personal communication) so we established the follow-
ing rules: from the seven questions on each daily diary, if
three responses or less were missing they were substituted
by the mean of the remainder; if more than three
responses were missing, that day's diary was discarded.
For the remaining outcome measures, no data substitu-
tions were made.
Analysis was descriptive and exploratory, using Excel and
SPSS. NRT use was calculated as the weekly mean of the
daily total mg of nicotine, using the pack data (e.g. 15 mg
for each nicotine 15 mg patch) for all products except for
the inhalator for which we used a reasoned estimate of 6
mg, in the absence of published data. MPSS scores were
total daily scores averaged for each week. Urge and consti-
pation scores were analysed separately. Analysis was
planned per protocol, as we would choose for an efficacy
study.
Results
With regard to accrual and dropouts, just under half the
smokers who attended four clinics (24 from 49) agreed to
participate and were randomised on the quit date. One
decided against using NRT so was excluded, and four did
not attend the following week so were presumed not to
have quit. Thus, 19 (39% of those invited) remained in
the study for at least one week after quitting, and 7 (14%)
remained throughout the study period (Figure 1). One
participant withdrew from the study at week 3 for lack of
perceived effect of acupressure, but continued to attend
the clinic.
Participants who dropped out of the study were slightly
older (47.5, SD 11.5 against 41.7, SD 14.0 years), and
reported median 2 previous quit attempts, compared with
6 in those who remained (z = 2.175, p = 0.030, Mann-
Whitney U test). Dropouts did not report higher daily
consumption of cigarettes, and were similar in nicotine
dependence scores, measured expired CO concentration
and prescribed form of NRT.
One participant (in group A) did not report pressing the
beads more than four times per day from the quit day
onwards, but was the only person to rate discomfort as
higher than 'slight' at the end of the first week. The other
participants reported pressing the bead more than 10
times most days at the beginning of the first week, but
only two were continuing at that frequency by the end of
the first week. By the end of the second week, only four
people reported stimulating it more than five times a day,
though one other person reported discomfort. In week
quit 3 four participants, and in week quit 4 three partici-
pants reported still pressing the bead more than five times
a day. Discomfort from the bead was scored as 'none' or
'slight' at the great majority of time points, though two
participants, both in group A, reported 'somewhat' on 3
and 4 days, respectively. There were several technical
problems with adhesiveness of the dressing: beads fre-
quently either fell off or moved around on the surface of
the ear (numbers not recorded). In response to the ques-
tion on adverse events, two patients reported 'soreness',
but no participant reported removing the bead on account
of soreness.
Completion rates for diaries varied for different outcomes.
Every participant who attended any clinic returned a diary
that was at least partially completed. Out of the 95 weeks'
diaries of MPSS data, six days (1%) contained too little
information to be included, and 15 other items were miss-
ing and required substitution (total missing data = 2.0%).
Missing data for urge scores were 1%, and for bead pres-
sure and discomfort 3%. Missing data were highest for the
number of doses of NRT used per day, at 10.2%. The
majority of data missing referred to the use of either a
patch, which could be accurately checked by questioning
at the subsequent clinic, or use of the second form of NRT
which is designed to be used less frequently so missing
data might result in only small errors in the analysis. The
alternative method for reporting NRT use – counting of
empty packets – was generally unsuccessful as very few
participants remembered to bring the packets back.Page 4 of 9
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CONSORT diagram of patient flow through the studyFigure 1
CONSORT diagram of patient flow through the study.
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taking NRT) n=1 
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vided outcome data for at least one week after randomisa-
tion, week quit 1. Their background characteristics and
summary of NRT interventions are given in Table 2. All
CO readings were ≤ 9 ppm except in one participant: on
week 3 the reading was 10 ppm, but subsequent readings
were 1 and 2 ppm. Therefore we considered all who
attended to be successful quitters: at the last attendance,
seven had quit, one in group A and three each in groups B
and C.
We limited the comparative analysis to weeks 3 and 5 (see
Tables 3 and 4), because of the dropout rate, particularly
the small number of participants attending on week 6 as
shown in Figure 2. The mean (SD) dose of NRT, based on
diary entries, used by participants in the three groups (A,
B, C) show no meaningful changes. Mean withdrawal
symptom scores (MPSS) are relatively constant through-
out the study in all groups (Tables 2 and 3) with no signif-
icant difference between group scores on any week (p >
0.5, Kruskal-Wallis for 3 independent groups). Mean
MPSS scores for all 19 participants were 11.8 (SD 2.9) and
12.8 (3.0) for the run-in week and quit week respectively.
Mean MPSS scores for the first two weeks were not higher
in participants who dropped out than those who
remained in the study: 11.3 (3.2) and 11.8 (2.8) for the
dropouts, and 12.8 (2.2) and 14.5 (2.9) for those who
stayed in the study at run-in and quit 1 weeks respectively.
There were no discernible differences between groups for
urges or constipation scores (data not presented).
In view of the lack of effects observable in the measured
outcomes, the researchers asked some of the participants
informally at the end of the study whether they had
noticed any discernible effect of the beads. One partici-
pant reported that pressing the bead 'definitely helped to
relax' her; one reported that 'it was a distraction only' and
four reported that the acupressure did not help. Two par-
ticipants dropped out of the study after reporting a lack of
any noticeable effect.
Discussion
This pilot study found that about half the smokers that
were seeking help from a local smoking advice service
were willing to try acupressure beads as an adjunct to
usual treatment, but the dropout rate during the five week
study was 84%. Compliance with instructions to press the
bead was good for the first week but then deteriorated.
Adverse events were minimal.
Each clinic of approximately 12 smokers generated about
five participants in the first week after the quit date, of
whom about two remained at the final (sixth) follow up.
High dropout rates are not unusual in trials of addiction.
We were surprised how little stimulation the participants
reported using, and how little discomfort the beads
caused: we designed the study on the premise that acu-
pressure needs to cause a perceptible stimulus for it to be
effective. The original observation of an effect of acupunc-
ture in heroin withdrawal involved electrical stimulation
of the needles,[6] and other authors have reported using a
surgical suture in the ear [24]. Stimulation of indwelling
devices is a consistent feature of reports of this method.
Diaries were returned efficiently, but recording of NRT
consumption was poor, probably because participants
thought we would assume that an NRT patch would be
used every day, and because participants found it difficult
to recall the use of variable items like gum or inhalator.
We noted wide variability in the reported consumption of
NRT, particularly in group B. This was due largely to two
participants in this group who did not use NRT patches:
Table 2: Background characteristics of three groups as analysed (means except where stated, with SDs in parentheses)
group A group B group C
n 6 6 7
males (n) 4 1 0
age in years 51.0 (7.9) 39.8 (18.2) 44.4 (8.4)
initial expired CO 23.7 (12.3) 17.2 (4.5) 19.5 (7.8)
cigs/day 17.5 (6.1) 16.5 (4.4) 17.5 (3.3)
years smoking 34.3 (6.3) 21.0 (11.4) 24.8 (11.2)
quit attempts 4.8 (6.7) 6.8 (6.9) 3.3 (1.9)
quits last 6 mo 0.5 1.0 0.4
live alone (n) 2 1 0
smoker in home (n) 1 1 1
modified Fagerstrom: max score 10 4.7 (1.6) 4.3 (1.5) 6.0 (2.0)
used NRT patch (n) 6 4 7
used 2 forms of NRT (n) 6 2 6
NRT = nicotine replacement therapyPage 6 of 9
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Table 4: Mean scores (SD) for main outcomes for participants attending the 5th clinic*
group A n = 4 group B n = 5 group C n = 4
Mean NRT consumption
quit week 208.8 (56.3) 122.4 (27.9) 179.0 (19.1)
FU1 week 202.5 (36.7) 143.6 (58.7) 162.5 (20.8)
FU2 week 173.3 (27.0) 150.0 (108.2) 152.5 (8.5)
Mean MPSS scores
Run-in week 13.1 (1.9) 11.4 (2.4) 12.2 (3.8)
Quit week 11.4 (2.4) 12.9 (1.9) 13.8 (4.0)
FU1 week 12.0 (3.4) 11.8 (3.7) 13.1 (4.7)
FU2 week 12.7 (4.1) 11.2 (3.8) 13.8 (5.1)
*insufficient data to analyse 6th (final) week
NRT = nicotine replacement therapy
FU = follow up
Table 3: Mean scores (SD) for main outcomes for participants attending 3rd clinic (first following quit date)
group A n = 6 group B n = 6 group C n = 7
Mean NRT consumption
Quit week 201.8 (80.4) 126.5 (26.9) 157.9 (32.1)
Mean MPSS scores
Run-in week 12.5 (2.9) 11.1 (2.2) 11.9 (3.6)
Quit week 12.2 (3.0) 12.6 (1.8) 13.4 (4.1)
NRT = nicotine replacement therapy
BMC Complementary and Alternative Medicine 2007, 7:8 http://www.biomedcentral.com/1472-6882/7/8one used small numbers of microtabs, taking only 16 mg
nicotine in the last week: another used large numbers of
nicotine gum 4 mg, amounting to 308 mg in the last week.
The alternative measure for NRT use, counting used packs,
was also unsuccessful. We conclude that further investiga-
tion of the best way to measure NRT consumption is
needed before this can be considered a suitable outcome
for a clinical trial.
In contrast, there were few missing data for MPSS scores.
The mean values scored by our participants (ranging
between about 11 and 14) are similar to those observed in
83 smokers in a previous study [22]. Daily scores rose dra-
matically in that study to about 18 among the 43 smokers
who voluntarily abstained, without nicotine replacement,
for 24 hours. The lack of any such increase in our partici-
pants is presumably due to the effects of NRT and the
behavioural intervention: either withdrawal symptoms do
not occur, or any that do occur are not detected by the
MPSS. The lack of any measurable increase in withdrawal
symptoms suggests a 'floor effect', i.e. that there is no pos-
sibility of measuring an additional effect of acupressure
because smoking withdrawal symptoms are already man-
aged effectively within the limits of current measurement
tools.
In addition, in interacting with the participants, we
detected an initial enthusiasm for trying acupressure at the
time of quitting, but a marked lack of enthusiasm for the
intervention at the end of the study. Future studies could
profitably explore the effectiveness of acupressure in
smokers who have chosen acupressure in preference to
NRT or bupropion using a patient preference design [25].
High levels of expectation could in themselves increase
the effectiveness of acupressure, and may improve com-
pliance with instructions to stimulate the bead. Open
studies should be conducted first to determine whether an
effect exists, then by blinded studies using a placebo inter-
vention, to test the causal relationship. We have not been
able to design a convincing placebo for acupressure beads.
Placebo-controlled studies of acupressure in smoking ces-
sation require careful consideration of the ethical aspects:
in view of the proven benefits of certain interventions,
and the life-threatening consequences of failure, smokers
should not be offered only a control intervention which
the researcher expects to be ineffective. This is why we ini-
tially sought a dose-related effect in our design, and why
we offered acupressure as an adjunct to known effective
treatment.
Conclusion
This pilot study suggests that any effects of acupressure on
NRT consumption or nicotine withdrawal symptoms in
smoking cessation, as an adjunct to the use of NRT and
behavioural intervention, are unlikely to be detectable by
the methods used in this study, and further preliminary
studies are required before the hypothesis can be tested.
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